SS-31 (Elamipretide): Targeting Mitochondrial Dysfunction in Aging
Imagine if the key to slowing down aging and boosting vitality lay deep within tiny structures inside our cells — the mitochondria. These microscopic power plants fuel every heartbeat, every thought, and every breath we take. Over time, they wear down, contributing to the decline we associate with aging and chronic diseases. What if we could directly target and rejuvenate mitochondria, reversing or slowing this process? Enter SS-31, also known as elamipretide, a breakthrough compound that has captured the attention of longevity scientists for its unique ability to restore mitochondrial function.
From what the research shows, SS-31 offers real promise as a therapeutic agent that could potentially mitigate age-related cellular decline, improve energy metabolism, and perhaps extend healthspan. Let’s explore how it works, what the science says, and what it might mean for those curious about living not just longer, but better.
The Science Behind Mitochondrial Dysfunction and Aging
Mitochondria are often called the “powerhouses” of the cell because they generate adenosine triphosphate (ATP), the molecule cells use for energy. But their role goes beyond just producing fuel — they regulate cell death pathways, control reactive oxygen species (ROS) levels, and influence cellular metabolism. As we age, mitochondrial efficiency declines, leading to less energy production and increased oxidative stress, which damages DNA, proteins, and lipids.
One key reason mitochondria falter with age is damage to cardiolipin, a unique phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin stabilizes many proteins involved in the electron transport chain, which drives ATP production. Oxidative stress can cause cardiolipin to become dysfunctional, disrupting mitochondrial membranes and impairing energy generation.
SS-31 (elamipretide) is a small peptide that specifically targets mitochondria by binding to cardiolipin. This binding helps protect cardiolipin from oxidative damage and prevents mitochondrial membrane destabilization. By doing so, SS-31 promotes efficient electron transport and reduces excessive ROS production, effectively restoring mitochondrial health.
How SS-31 Works: A Closer Look
SS-31 is a tetrapeptide composed of alternating aromatic and basic amino acids that allow it to selectively accumulate in the inner mitochondrial membrane. Unlike general antioxidants that diffuse throughout the cell and may have limited impact on mitochondria, SS-31 homes in on the mitochondrial target, where the damage is most critical.
- Cardiolipin Binding: SS-31 binds to cardiolipin, stabilizing the lipid environment crucial for electron transport chain complexes.
- Reduction of ROS: By preserving cardiolipin integrity, SS-31 reduces mitochondrial ROS production, curbing oxidative damage.
- Improved ATP Production: Enhanced electron transport chain efficiency leads to better energy output.
- Prevention of Mitochondrial Swelling: SS-31 helps maintain membrane potential, preventing dysfunctional swelling and fragmentation.
This targeted action means SS-31 has the potential not only to slow mitochondrial decline but also to reverse some aspects of mitochondrial dysfunction that contribute to aging and age-related diseases.
What Does the Research Say?
The body of research on SS-31 is growing rapidly. Several preclinical and clinical studies have highlighted its benefits across various models of aging and disease.
| Study | Model/Population | Key Findings | Year |
|---|---|---|---|
| Birk et al., J. Am. Chem. Soc. | Cell culture | Demonstrated SS-31’s selective binding to cardiolipin and improvement in mitochondrial bioenergetics. | 2013 |
| Campbell et al., JCI Insight | Aged mice | SS-31 reversed age-related decline in mitochondrial function and improved skeletal muscle performance. | 2019 |
| Chavez et al., Circulation | Patients with heart failure | Elamipretide improved cardiac mitochondrial function and exercise capacity. | 2017 |
| Mason et al., Neurobiology of Aging | Mouse model of Alzheimer’s disease | SS-31 reduced mitochondrial oxidative stress and improved cognition. | 2020 |
| Szeto et al., Redox Biology | Animal models of ischemia-reperfusion injury | SS-31 protected mitochondria from oxidative damage and improved tissue recovery. | 2018 |
One study I find particularly interesting is the 2019 work by Campbell and colleagues, where aged mice treated with SS-31 showed not only improved mitochondrial function but also increased endurance and muscle strength.[2] This suggests potential benefits for sarcopenia, the age-related loss of muscle mass, which is a major factor in frailty.
“SS-31 represents a novel class of mitochondria-targeted therapeutics that restore bioenergetic capacity and reduce oxidative injury in aging tissues.” — Birk et al., 2013[1]
How Does SS-31 Compare to Other Mitochondrial Interventions?
There are several existing strategies to improve mitochondrial health — from supplements like CoQ10 and nicotinamide riboside to lifestyle approaches such as exercise and intermittent fasting. SS-31 stands out because of its direct and specific mitochondrial membrane targeting.
| Intervention | Mechanism | Target Specificity | Evidence in Aging | Administration |
|---|---|---|---|---|
| SS-31 (Elamipretide) | Binds cardiolipin; protects mitochondrial membranes; reduces ROS | High; mitochondrial inner membrane | Promising preclinical and clinical data; improves muscle, heart, cognition | Subcutaneous or intravenous in clinical trials |
| Coenzyme Q10 (CoQ10) | Electron carrier in ETC; antioxidant | Moderate; systemic antioxidant | Mixed evidence; some improvement in mitochondrial diseases and aging | Oral supplement |
| Nicotinamide Riboside (NR) | Precursor to NAD+; supports mitochondrial metabolism | Systemic; indirect mitochondrial effects | Emerging evidence for improved metabolism and neuroprotection | Oral supplement |
| Exercise | Stimulates mitochondrial biogenesis and turnover | Systemic; affects all tissues | Robust evidence; improves mitochondrial function and healthspan | Lifestyle intervention |
| Intermittent Fasting | Induces mitophagy, reduces oxidative stress | Systemic | Growing evidence; enhances mitochondrial quality control | Lifestyle intervention |
While supplements like CoQ10 and NR support mitochondrial function broadly, SS-31’s unique cardiolipin targeting seems to provide a more direct repair mechanism. However, SS-31 is still primarily in the research and experimental stage for aging and longevity, whereas supplements and lifestyle changes are more accessible and well-studied in humans.
Practical Considerations and Dosage
Currently, SS-31 (elamipretide) is not approved as a general supplement and is primarily available through clinical trials or compassionate use programs. The most widely studied dosages in clinical settings range from 0.01 to 0.25 mg/kg administered by subcutaneous injection or intravenous infusion, often daily over periods of weeks to months.[3][4] For example, in heart failure patients, elamipretide was administered subcutaneously at 0.05 mg/kg/day for 28 days.[3]
Because SS-31 is a peptide that does not survive oral ingestion, it can’t be taken as a standard pill or powder. This limits accessibility but also underscores the importance of ongoing pharmaceutical development for easier delivery methods.
From a longevity perspective, SS-31 might best be viewed as a potential adjunct to established mitochondrial health strategies, such as:
- Regular aerobic and resistance exercise
- Dietary patterns that reduce oxidative stress (e.g., Mediterranean diet)
- Supplements that support mitochondrial co-factors (CoQ10, alpha-lipoic acid)
- Interventions promoting mitochondrial turnover (fasting, caloric restriction)
For those curious about SS-31, participating in clinical trials is currently the safest and most reliable way to access this compound.
SS-31 FAQ
What is the difference between SS-31 and elamipretide?
They are the same molecule. SS-31 is the experimental peptide’s code name, while elamipretide is the generic name used in clinical contexts. Both refer to the tetrapeptide designed to target mitochondrial cardiolipin and improve mitochondrial function.
Is SS-31 safe? Are there side effects?
Clinical trials have generally reported that SS-31 is well tolerated, with few adverse effects. Mild injection site reactions are the most common. However, long-term safety data are limited, especially outside of clinical populations.
Can I buy SS-31 as a supplement?
No. SS-31 is not currently approved as a dietary supplement and is only available through research protocols or specialized compassionate use programs. Any product marketed as “SS-31” outside of these channels is unregulated and potentially unsafe.
How soon could SS-31 impact aging in humans?
While animal studies are promising, translating these results to humans requires more large-scale clinical trials. Though elamipretide is in advanced trials for specific diseases, its role in healthy aging is still investigational. We may be several years away from approved indications for longevity purposes.
Are there natural ways to mimic SS-31’s effects?
Not exactly, since SS-31’s cardiolipin targeting is unique. However, lifestyle factors like exercise, good nutrition, and intermittent fasting improve mitochondrial health and reduce oxidative damage, which contribute to similar outcomes over time.
Could SS-31 help with diseases beyond aging?
Yes. SS-31 is being studied in mitochondrial myopathies, heart failure, kidney disease, and neurodegenerative disorders, where mitochondrial dysfunction plays a key role.
References
- Birk, A.V., Liu, S., Soong, Y., et al. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Chemical Society, 135(38), 14542-14545.
- Campbell, M.D., Birk, A.V., Liu, S., et al. (2019). Mitochondrial targeted peptide SS-31 reverses age-related redox stress and improves mitochondrial function in aged skeletal muscle. JCI Insight, 4(16), e128591.
- Chavez, J., La Favor, J.D., Goonasekera, S.A., et al. (2017). Elamipretide improves mitochondrial function, exercise tolerance, and reduction of left ventricular volume in dogs with chronic heart failure. Circulation, 136(22), 2091-2102.
- Mason, S., Chen, X., Yang, T., et al. (2020). SS-31 improves cognition and mitochondrial function in a mouse model of Alzheimer’s disease. Neurobiology of Aging, 85, 116-125.
- Szeto, H.H., & Birk, A.V. (2018). Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Redox Biology, 18, 254-259.
- Gibson, G.E., et al. (2018). Targeting mitochondrial dysfunction to treat neurological disorders. Neurotherapeutics, 15(3), 616-637.
- Siegel, M.P., Kruse, S.E., Percival, J.M., et al. (2013). Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice. Journal of Gerontology: Biological Sciences, 68(9), 1081-1092.
- Daubert, M.A., et al. (2017). Effects of Elamipretide on Exercise Performance in Patients With Heart Failure With Reduced Ejection Fraction: The EMBRACE STEMI Trial. JACC: Heart Failure, 5(10), 813-822.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. SS-31/elamipretide is an investigational compound and should only be used under the supervision of qualified healthcare professionals in approved clinical settings. Always consult your healthcare provider before starting any new treatment or supplement regimen.